Aterian (ATER) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
11 Jun, 2026Executive summary
Special Meeting scheduled for July 10, 2026, to vote on key proposals including asset sale, director elections, and capital structure changes.
Proxy materials clarify voting options and procedures, including the ability to withhold votes for director nominees.
Board recommends voting "FOR" all proposals, including director nominees and structural amendments.
Voting matters and shareholder proposals
Proposals include asset sale, director elections, change of control, related party transactions, issuance of shares, reverse stock split, authorized stock increase, and adjournment.
Director Election Proposal allows votes "FOR" or "WITHHOLD" for each nominee; plurality of "FOR" votes required for election.
Asset Sale Proposal requires majority of outstanding shares; abstentions and broker non-votes count as "AGAINST."
Other proposals generally require majority of votes cast, with abstentions and broker non-votes having no effect.
Quorum set at 3,616,470 shares; abstentions, withhold votes, and broker non-votes count toward quorum.
Board of directors and corporate governance
Two nominees, Avraham Ben-Tzi and David Natan, are up for election as Class I directors with terms ending in 2027 and 2028, respectively.
Board continues to recommend all proposals and director nominees.
Latest events from Aterian
- Shareholders will vote on major asset sale, strategic investment, and capital structure changes.ATER
Proxy filing18 Jun 2026 - Vote on asset sale, $7M investment, board overhaul, and major capital changes recommended FOR.ATER
Proxy filing9 Jun 2026 - Approval sought for asset sale, new investment, board overhaul, and major capital structure changes.ATER
Proxy filing8 Jun 2026 - Asset sale, recapitalization, and board overhaul proposed to address liquidity and strategic challenges.ATER
Proxy filing1 Jun 2026 - Asset sale, major investment, board overhaul, and capital structure changes recommended for approval.ATER
Proxy filing15 May 2026 - Major asset sale and recapitalization planned amid steep losses and going concern risks.ATER
Q1 202615 May 2026 - Asset sale and strategic investment will transfer control to David Lazar, pending shareholder approval.ATER
Proxy filing29 Apr 2026 - Revenue dropped 30% and net loss widened as tariffs and weak demand pressured results.ATER
Q4 202523 Mar 2026 - Q2 guidance raised and new leadership named; profitability targeted for H2 2024.ATER
Investor Update3 Feb 2026